Author:
Keith Benjamin P.,Barrow Jasmine B.,Toyonaga Takahiko,Kazgan Nevzat,O’Connor Michelle Hoffner,Shah Neil D.,Schaner Matthew S.,Wolber Elisabeth A.,Trad Omar K.,Gipson Greg R.,Pitman Wendy A.,Kanke Matthew,Saxena Shruti J.,Chaumont Nicole,Sadiq Timothy S.,Koruda Mark J.,Cotney Paul A.,Allbritton Nancy,Trembath Dimitri G.,Sylvester Francisco,Furey Terrence S.,Sethupathy Praveen,Sheikh Shehzad Z.
Abstract
AbstractCrohn’s disease (CD) is highly heterogeneous, due in large part to variability in cellular processes that underlie the natural history of CD, thereby confounding effective therapy. There is a critical need to advance understanding of the cellular mechanisms that drive CD heterogeneity. In this study, small RNA-sequencing and microRNA profiling in the colon revealed two distinct molecular subtypes, each with different clinical associations, in both adult and treatment-naïve pediatric CD patients. Notably, we found that microRNA-31 (miR-31) expression by itself can stratify patients into these two subtypes. Through detailed analysis of several colonic mucosa cell types from adult patients, we found that differential levels of miR-31 are particularly pronounced in epithelial cells. We generated patient crypt-derived epithelial colonoids and showed that miR-31 expression differences preserved in this ex-vivo system. In adult patients, low colonic miR-31 expression levels at the time of surgery are associated with post-operative recurrence of ileal disease. In pediatric patients, lower miR-31 expression at the time of diagnosis is associated with the future development of fibrostenotic ileal CD requiring surgery. These findings represent an important step forward in designing more effective clinical trials and developing personalized therapies for CD.
Publisher
Cold Spring Harbor Laboratory